PDCD1 and posterior cortical atrophy: Although promising in multiple malignancies, immunotherapy provides few options with currently less than significant results for PCa, including programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte antigen 4 (CTLA-4) blockage and vaccine-based pharmaceuticals (25, 26).